Out of a total of 5,552 subjects, 55 2.41% of the 2,278 patients who had had H. pylori eradicated developed gastric cancer, but 96 4.22% of the 2,272 patients who had not had the bacteria eradicated developed gastric cancer RR: 0.57, CI = 0.42 to 0.79.
Con un total de 5.552 sujetos, se encontró desarrollo de cáncer gástrico en 55 2,41% de 2278 pacientes a quienes se erradicó el H. pylori y en 96 4,22% de 2.272 a quienes no se les erradicó, RR: 0,57 IC= 0,42-0,79.